Rein Therapeutics
Price & Volume
Stats
See more52W Range | $0.69-$2.18 |
Market Cap | $68.1M |
Shares Short | 670,748 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.86 |
News
See moreYahoo Finance • 5 months ago
Rein Therapeutics Announces Pricing of $50 Million Underwritten Public Offering of Common Stock
Yahoo Finance • 11 months ago
Rein Therapeutics Receives FDA Clearance to Resume U.S. Phase 2 Trial of LTI-03 in Idiopathic Pulmonary Fibrosis
About
CEO | Dr. James Brian Windsor Ph.D. |
Address | 12407 N. Mopac Expy., Austin, TX, United States, 78758 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 10 |